Headlines

Inovio Pharmaceuticals Stock Is 16% Down In The Last 5 Sessions

Shares of biotechnology company Inovio Pharmaceuticals (NASDAQ: INO) have recently been on a sharp decline. Over the course of five consecutive sessions, the company’s stock plummeted by more than 16%, dropping to sh.42. This drop contributed significantly to NATDAQ’s overall decrease of 1.12%. As of now, Inovio Pharmaceuticals’ shares are trading at prices 84.93% lower…

Read More

FibroGen And Sypris Solutions On The List Of Winners And Losers Of Tuesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are FibroGen, Banco Bradesco, and Inovio Pharmaceuticals. Rank Financial Asset Price PremarketChange Updated (EST) 1 FibroGen (FGEN) 1.91 7.91% 2023-08-08 04:09:14 2…

Read More

Inovio Pharmaceuticals Stock Falls By 19% In The Last 5 Sessions

Biotechnology firm Inovio Pharmaceuticals has recently faced some challenges in the marketplace. The firm saw a significant decline of 19.17% over five consecutive sessions. This downturn coincided with a general decrease of 0.13% across four continuous losing sessions on the NASDAQ exchange. Focus on SynCon DNA Medicines Despite their disappointing market performance, Inovio Pharmaceuticals remains…

Read More

Gevo And Xenetic Biosciences On The List Of Winners And Losers Of Friday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are Gevo, Inovio Pharmaceuticals, and Infosys Limited. Rank Financial Asset Price PremarketChange Updated (EST) 1 Gevo (GEVO) 1.64 3.14% 2023-08-04 07:09:51 2…

Read More

Inovio Pharmaceuticals Stock Jumps By 30% In The Last 21 Sessions

Inovio Pharmaceuticals’ stock price observed a considerable increase of 30.49% over 21 sessions, escalating from sh.4 on June 27, 2023, to sh.52 on a subsequent Wednesday. This increase was witnessed despite NASDAQ experiencing a 0.12% dip to 127.28. Nevertheless, Inovio continues to remain significantly below its 52-week high at 81.73%, regardless of this upward momentum….

Read More

Tilray And IShares Short-Term On The List Of Winners And Losers Of Wednesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are Tilray, Canopy Growth, and Fox Corporation. Rank Financial Asset Price PremarketChange Updated (EST) 1 Tilray (TLRY) 1.94 15.57% 2023-07-26 07:30:33 2…

Read More

Niu Technologies And NeuroMetrix On The List Of Winners And Losers Of Tuesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are Niu Technologies, iRobot, and Inovio Pharmaceuticals. Rank Financial Asset Price PremarketChange Updated (EST) 1 Niu Technologies (NIU) 3.96 2.86% 2023-07-25 07:14:23…

Read More

Inovio Pharmaceuticals Stock Slides 9% So Far On Monday, Underperforms Market

Shares of Inovio Pharmaceuticals (NASDAQ: INO) saw a decline in the stock market, marking two consecutive sessions of losses on NASDAQ. Falling 9.11% to $12.47 as of 12:38 EST Monday morning, these losses took place even as NASDAQ itself experienced an upward movement of 0.21% to $15,062.46. Prior Performance of Inovio Pharmaceuticals Inovio Pharmaceuticals ended…

Read More

Inovio Pharmaceuticals And Sypris Solutions On The List Of Winners And Losers Of Thursday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are Inovio Pharmaceuticals, Canopy Growth, and Banco Bradesco. Rank Financial Asset Price PremarketChange Updated (EST) 1 Inovio Pharmaceuticals (INO) 0.59 2.9% 2023-07-20…

Read More